FDA recall record

Immuno-Mycologics Immy, Myco DDR Trident, Bulk Neutralization Buffer B (60 X 30 mL), REF recall — FDA Z-1984-2026

Neutralization Buffer may contain contaminants

Class IIclassification
Z-1984-2026official record ID
May 6, 2026report date

Recall record at a glance

Official recordZ-1984-2026
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmImmuno-Mycologics, Inc
Report dateMay 6, 2026
Recall initiation dateMar 26, 2026
Quantity101 units
LocationNorman, OK, United States

Official product description

Immy, Myco DDR Trident, Bulk Neutralization Buffer B (60 X 30 mL), REF: TBPN67-60 For processing of clinical specimens for Mycobacterium spp. diagnosis

Why the product was recalled

Neutralization Buffer may contain contaminants

Distribution information

US Nationwide distribution in the states of AZ, MS, SC, CT, NC, TX, IN, WA, MO, MI, CA.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: not stated.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.